Advances in biomarkers for differential diagnosis of autoimmune and autoinflammatory inner ear disorders
Molecular Biology Reports · 2026
DOI: 10.1007/s11033-026-12201-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Shabnam Eskandarzadeh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Biomarkers, Autoimmune Inner Ear Disease, Labyrinth Diseases, Autoimmune Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben.
Abstract (Originalsprache)
Autoimmune inner ear disease (AIED) represents a rare yet potentially reversible cause of sensorineural hearing loss, characterized by immune-mediated damage to cochlear and vestibular structures. Unlike autoimmunity, which is driven by adaptive immune responses and autoantibodies, autoinflammation stems from innate immune system dysregulation, typically involving inflammasome hyperactivation. This review synthesizes recent advancements in biomarkers for the differential diagnosis of AIED, emphasizing their role in distinguishing it from conditions such as Meniere's disease (MD) and chronic otitis media (COM). Autoantibodies and cytokines, including anti-heat shock protein 70 (HSP70), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), antiphospholipid antibodies, anti-type II collagen, selective immunoglobulin A deficiency (sIgAD), and anti-cochlin antibodies, have a significant role in diagnostic sensitivity, specificity, and correlations with treatment responsiveness. Additionally, we discuss the utility of magnetic resonance imaging (MRI) in identifying inner ear enhancements and propose diagnostic algorithms to facilitate early detection. By integrating serological, immunological, and radiological insights, this work underscores the potential of these biomarkers to guide personalized therapeutic strategies, including corticosteroids and biologics, while addressing diagnostic challenges and the need for standardized criteria. Ultimately, enhanced biomarker utilization may improve outcomes in AIED by enabling timely intervention and reducing misdiagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. faraji65@gmail.com.
- Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. masoud.lahouty.tbz@gmail.com.
Zitieren
APA
Eskandarzadeh, S., Akhijahani, R. F., & Lahouty, M. (2026). Advances in biomarkers for differential diagnosis of autoimmune and autoinflammatory inner ear disorders. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12201-2
Vancouver
Eskandarzadeh S, Akhijahani RF, Lahouty M. Advances in biomarkers for differential diagnosis of autoimmune and autoinflammatory inner ear disorders. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12201-2
BibTeX
@article{Eskandarzadeh2026,
author = {Eskandarzadeh, Shabnam and Akhijahani, Roghaye Faraji and Lahouty, Masoud},
title = {Advances in biomarkers for differential diagnosis of autoimmune and autoinflammatory inner ear disorders},
journal = {Molecular Biology Reports},
year = {2026},
doi = {10.1007/s11033-026-12201-2}
}
EUVIMED